Merck seeks first U.S. authorization for COVID-19 pill
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
EU may consider deal on Merck's (MRK) COVID pill after approval procedure begins - source - Reuters
October 12, 2021 10:39 AM EDTEU may consider deal on Merck's (NYSE: MRK) COVID pill after approval procedure begins - source - Reuters
... MoreUPDATE: Merck (MRK) Commences Cash Tender Offer to Acquire Acceleron Pharma (XLRN) for $180/sh, Deal Announced on Sept. 30
October 12, 2021 6:47 AM EDT(Updated - October 12, 2021 6:51 AM EDT)
Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron Pharma Inc. (Nasdaq: XLRN). On Sept. 30, 2021, Merck announced that it had entered into a... More



